Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
4
×
boston top stories
life sciences
national blog main
clinical trials
national top stories
new york blog main
new york top stories
san francisco blog main
boston
cancer drugs
deals
europe blog main
fda
investing
san francisco top stories
startups
acute myeloid leukemia
alx oncology
antisense oligonucleotide
autoimmune diseases
azacitidine
benzodiazepines
berkeley lights
beta-thalassemia
biogen
biotech ipos
black diamond therapeutics
blackstone group
blackstone life sciences
bladder cancer
blueprint medicines
cancer
cancer immunotherapy
cd47
chronic kidney disease
columbia university
dacogen
david goldstein
What
new
4
×
research
4
×
biotech
medicines
aims
companies
drugs
ipo
therapeutics
approach
arrival
backed
based
black
called
cancer
cause
ceo
clinic
days
debuts
developing
diamond
drug
eluded
epigenetic
epigenetics
epilepsy
field
flagship’s
genes
genetic
hasn’t
hopes
industry
ipos
lead
leading
life
lines
Language
unset
Current search:
new
×
" boston blog main "
×
research
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further